Predictive Cancer Model Clinical Trial
Official title:
Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer
Platinum-sensitive is an important basis for the treatment of recurrent epithelial ovarian cancer (EOC) without effective methods to predict.We aimed to develop and validate the EOC deep learning system to predict the platinum-sensitive of EOC patients through analysis of enhanced magnetic resonance imaging (MRI) images before initial treatment.Ninety-three EOC patients received platinum-based chemotherapy (>= 4 cycles) and debulking surgery from Sun Yat-sen Memorial Hospitalin China from January 2011 to January 2020 were enrolled. This deep-learning EOC signature achieved a high predictive power for platinum-sensitive, and the signature based on MRI whole volume is better than that on primary tumor area only.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06023966 -
A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery
|
||
| Recruiting |
NCT04535466 -
Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics
|
||
| Recruiting |
NCT03280134 -
A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer
|
N/A | |
| Recruiting |
NCT03253107 -
Predicting Biomarker of Gastric Cancer Chemotherapy Response
|
||
| Recruiting |
NCT06364371 -
Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer
|
||
| Recruiting |
NCT05997147 -
A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma
|
||
| Recruiting |
NCT05929365 -
Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype
|
||
| Active, not recruiting |
NCT05973331 -
Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
|
||
| Recruiting |
NCT05338073 -
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
|
||
| Recruiting |
NCT06391892 -
Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery
|
Phase 3 | |
| Recruiting |
NCT06202404 -
Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model
|
||
| Completed |
NCT06411015 -
Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases
|
||
| Completed |
NCT04079283 -
Radiomics of Immunotherapeutics Response Evaluation and Prediction
|
||
| Completed |
NCT06092918 -
Generation and Validation of Predictive Models for Localized Prostate Cancer Treated With External Radiotherapy.
|
||
| Recruiting |
NCT06339307 -
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients
|
||
| Recruiting |
NCT04185779 -
COLO-COHORT (Colorectal Cancer Cohort) Study
|
||
| Active, not recruiting |
NCT06074029 -
Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05741944 -
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients
|
N/A | |
| Recruiting |
NCT04452058 -
CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC
|
||
| Active, not recruiting |
NCT06140823 -
Prospective Validation of Liver Cancer Risk Computation (LIRIC) Models
|